SNBL USA Moves Forward With Provantis Preclinical Solution Implementation

The commitment and investment in providing clients with the highest quality preclinical study data continues at SNBL

SNBL USA, contract research organization and the leader in NHP experience and expertise, announced it is on track with the implementation and launch of Instem’s Provantis® preclinical software solution suite in November 2012. SNBL USA will be using the flexible Provantis solution suite as its official data collection system, demonstrating the Company’s on-going commitment to offer biotechnology and pharmaceutical clients unparalleled quality in both science and service.

SNBL USA will use all modules included within the integrated Provantis solution suite. The solution suite includes Instem’s latest Data Import module which will enable SNBL USA to seamlessly pull a broad range of external information into Provantis from clinical pathology to Estrous Cycle and Bone Assessment data. SNBL USA will also deploy Instem’s Dispense solution for test and control article inventory. Essentially, this system implementation in conjunction with SNBL’s team expertise ensures the highest quality data possible in support of the drug development process.
 

SNBL USA’s evaluation began with Instem’s Toxicology Resource Planning (TRP) solution. TRP manages studies, resources, equipment, animals and facilities to enable improved study throughput and increased up-time with less administrative overhead. Using TRP, SNBL USA will be able to initiate projects quicker, generate more value from physical assets, and monitor the status of studies in real time while keeping plans consistent and on track.

“Implementing Provantis demonstrates SNBL’s commitment to investing in the future,” said Dr. Thomas Beck, SNBL USA President and COO. “We can provide our clients the most accurate, timely reports facilitated by the efficient processes available through the utilization of Provantis. The unique combination of our NHP experience and expertise, our patented procedure cage and now the state of the art data collection system positions SNBL USA to better serve our existing and future clients.”

About Provantis®
Provantis is a modern, fully integrated software system for single users and global organizations engaged in preclinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment, on-site or over the Web.

About Instem
Instem is a world-leading information solutions provider to the life sciences - accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products. In addition to highly focused departmental and scientific solutions, Instem provides a range of business intelligence, planning, workflow management, document management and report compilation applications. Instem supports clients around the world through full service offices in the United States, United Kingdom and China. Instem additionally has resource locations in India and a full service distributor based in Japan. To learn more about Instem solutions and its mission, please visit www.instem.com.
 

About SNBL USA, Ltd.
Headquartered in Everett, WA, SNBL USA, Ltd. offers a unique range of safety assessment services to support the drug development process. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, we offer programs ranging from regulatory toxicology to customized study designs and disease models. Our specialized capabilities include safety assessment of biologics, reproductive toxicology, cardiovascular, respiratory and CNS pharmacology, immunotoxicology and carcinogenicity. SNBL USA’s state of the art facility can house up to 4,000 NHPs. Our standing in-house colony assures a quick study start. Through a commitment to investment and excellence, SNBL USA strives to offer the biotechnology and pharmaceutical industries unparalleled quality in both science and service. For additional information call 425.407.0121 or visit www.snblusa.com.

SNBL USA is a wholly-owned subsidiary of Shin Nippon Biomedical Laboratories, Ltd. (SNBL), one of the largest CROs in Japan. With its multiple worldwide facilities and countless skilled and experienced scientists and technicians, SNBL Group works together in providing a full range of drug development services.